A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06630247 · TERMINATED

Trial details

NCT number: NCT06630247
Sponsor: Exelixis
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Cancers Solid Tumor Cancer Solid Tumor Malignancy Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)Metastatic Solid Tumor Locally Advanced Solid Tumor Urothelial Cancer of Renal Pelvis

Start date: 2024-10-17
Primary completion: 2025-05-07
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.